Concepedia

Yuki Yajima

YY

Statistics

Publications

10

Citations

395

H-Index

10

Active since

2003

Affiliations

Asahikawa Medical University(Current)

Kobe Pharmaceutical University

Augusta University

Augusta University Health

Yuki Yajima is an author at Asahikawa Medical University specializing in oncology, cancer immunotherapy, and cancer immunology.

ORCID

Publications per year

2003–2022

10

Publications

10

Structural characterization of the epitopes of the monoclonal antibodies 473HD, CS-56, and MO-225 specific for chondroitin sulfate D-type using the oligosaccharide library

Yumi Ito, Megumi Hikino, Yuki Yajima et al. · Glycobiology · 2004 · 113 citations · Full text

, , +17

Heterogeneity of the Chondroitin Sulfate Portion of Phosphacan/6B4 Proteoglycan Regulates Its Binding Affinity for Pleiotrophin/Heparin Binding Growth-associated Molecule

Nobuaki Maeda, Jue He, Yuki Yajima et al. · Journal of Biological Chemistry · 2003 · 96 citations · Full text

, , +14

CD47 blockade enhances the efficacy of intratumoral STING-targeting therapy by activating phagocytes

Akemi Kosaka, Kei Ishibashi, Toshihiro Nagato et al. · The Journal of Experimental Medicine · 2021 · 55 citations · Full text

, , +17

Intratumoral STING activations overcome negative impact of cisplatin on antitumor immunity by inflaming tumor microenvironment in squamous cell carcinoma

Shohei Harabuchi, Akemi Kosaka, Yuki Yajima et al. · Biochemical and Biophysical Research Communications · 2019 · 27 citations · Full text

, , +17

A critical role of STING-triggered tumor-migrating neutrophils for anti-tumor effect of intratumoral cGAMP treatment

Marino Nagata, Akemi Kosaka, Yuki Yajima et al. · Cancer Immunology Immunotherapy · 2021 · 27 citations · Full text

, , +17

1–5 of 10